Cargando…

Radiomic signature of the FOWARC trial predicts pathological response to neoadjuvant treatment in rectal cancer

BACKGROUND: We aimed to develop a radiomic model based on pre-treatment computed tomography (CT) to predict the pathological complete response (pCR) in patients with rectal cancer after neoadjuvant treatment and tried to integrate our model with magnetic resonance imaging (MRI)-based radiomic signat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhuang, Zhuokai, Liu, Zongchao, Li, Juan, Wang, Xiaolin, Xie, Peiyi, Xiong, Fei, Hu, Jiancong, Meng, Xiaochun, Huang, Meijin, Deng, Yanhong, Lan, Ping, Yu, Huichuan, Luo, Yanxin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8194221/ https://www.ncbi.nlm.nih.gov/pubmed/34112180 http://dx.doi.org/10.1186/s12967-021-02919-x

Ejemplares similares

CEA clearance pattern as a predictor of tumor response to neoadjuvant treatment in rectal cancer: a post-hoc analysis of FOWARC trial
por: Hu, Huabin, et al.
Publicado: (2018)

Clinical spectrum of rectal cancer identifies hallmarks of early‐onset patients and next‐generation treatment strategies
por: Shen, Dingcheng, et al.
Publicado: (2022)

Nomogram basing pre-treatment parameters predicting early response for locally advanced rectal cancer with neoadjuvant chemotherapy alone: a subgroup efficacy analysis of FOWARC study
por: Zhang, Jianwei, et al.
Publicado: (2015)

Neoadjuvant Modified FOLFOX6 With or Without Radiation Versus Fluorouracil Plus Radiation for Locally Advanced Rectal Cancer: Final Results of the Chinese FOWARC Trial
por: Deng, Yanhong, et al.
Publicado: (2019)

Development and external validation of prognostic nomograms for liver disease-free and overall survival in locally advanced rectal cancer with neoadjuvant therapy: a post cohort study based on the FOWARC trial
por: Zhou, Jiaming, et al.
Publicado: (2022)

Time to lowest postoperative carcinoembryonic antigen level is predictive on survival outcome in rectal cancer
por: Yu, Huichuan, et al.
Publicado: (2016)

Radiological lymph‐node size improves the prognostic value of systemic inflammation index in rectal cancer with pathologically negative nodes
por: Peng, Shaoyong, et al.
Publicado: (2023)

Effect of interval between preoperative radiotherapy and surgery on clinical outcome and radiation proctitis in rectal cancer from FOWARC trial
por: Cheng, Yi‐Kan, et al.
Publicado: (2019)

Improved Survival Outcome and Access to Cancer Screening from Hemorrhoid in Patients with Rectal Cancer
por: Zou, Qi, et al.
Publicado: (2020)

Current treatment and surveillance modalities are not sufficient for advanced stage III colon cancer: Result from a multicenter cohort analysis
por: Li, Juan, et al.
Publicado: (2021)

Radiomics Signature Based on Support Vector Machines for the Prediction of Pathological Complete Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer
por: Li, Chao, et al.
Publicado: (2023)

Automatic treatment outcome prediction with DeepInteg based on multimodal radiological images in rectal cancer
por: Hu, Yihuang, et al.
Publicado: (2023)

Deep learning radiomics-based prediction of distant metastasis in patients with locally advanced rectal cancer after neoadjuvant chemoradiotherapy: A multicentre study
por: Liu, Xiangyu, et al.
Publicado: (2021)

Nomograms for Prediction of Molecular Phenotypes in Colorectal Cancer
por: Yu, Zhuojun, et al.
Publicado: (2020)

Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy alone for patients with locally advanced rectal cancer: a propensity-score-matched analysis combined with SEER validation
por: Wu, Jingjing, et al.
Publicado: (2023)

CT-based radiomic signatures for prediction of pathologic complete response in esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy
por: Yang, Zhining, et al.
Publicado: (2019)

Local tuning of radiomics-based model for predicting pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer
por: Tang, Bin, et al.
Publicado: (2022)

RNA demethylase ALKBH5 promotes colorectal cancer progression by posttranscriptional activation of RAB5A in an m6A‐YTHDF2‐dependent manner
por: Shen, Dingcheng, et al.
Publicado: (2023)

Radiomics for the Prediction of Pathological Complete Response to Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer: A Prospective Observational Trial
por: Shi, Liming, et al.
Publicado: (2023)

Clinical atlas of rectal cancer highlights the barriers and insufficient interventions underlying the unfavorable outcomes in older patients
por: Zhao, Zhuoyang, et al.
Publicado: (2023)

Predicting pathologic complete response in locally advanced rectal cancer patients after neoadjuvant therapy: a machine learning model using XGBoost
por: Chen, Xijie, et al.
Publicado: (2022)

Radiomics Approaches for the Prediction of Pathological Complete Response after Neoadjuvant Treatment in Locally Advanced Rectal Cancer: Ready for Prime Time?
por: Bourbonne, Vincent, et al.
Publicado: (2023)

Correction to: Predicting pathologic complete response in locally advanced rectal cancer patients after neoadjuvant therapy: a machine learning model using XGBoost
por: Chen, Xijie, et al.
Publicado: (2022)

Pretreatment CT and PET radiomics predicting rectal cancer patients in response to neoadjuvant chemoradiotherapy
por: Yuan, Zhigang, et al.
Publicado: (2021)

MRI radiomics independent of clinical baseline characteristics and neoadjuvant treatment modalities predicts response to neoadjuvant therapy in rectal cancer
por: Song, Maxiaowei, et al.
Publicado: (2022)

MRI-based pre-Radiomics and delta-Radiomics models accurately predict the post-treatment response of rectal adenocarcinoma to neoadjuvant chemoradiotherapy
por: Wang, Likun, et al.
Publicado: (2023)

A 41-Gene Pair Signature for Predicting the Pathological Response of Locally Advanced Rectal Cancer to Neoadjuvant Chemoradiation
por: Xue, Zhengfa, et al.
Publicado: (2021)

Ability of Delta Radiomics to Predict a Complete Pathological Response in Patients with Loco-Regional Rectal Cancer Addressed to Neoadjuvant Chemo-Radiation and Surgery
por: Nardone, Valerio, et al.
Publicado: (2022)

MRI-Based Radiomics Predicts Tumor Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer
por: Yi, Xiaoping, et al.
Publicado: (2019)

Radiomics-Based Pretherapeutic Prediction of Non-response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer
por: Zhou, Xuezhi, et al.
Publicado: (2019)

External Validation of a Radiomics Model for the Prediction of Complete Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer
por: Bordron, Anaïs, et al.
Publicado: (2022)

Predicting outcomes for locally advanced rectal cancer treated with neoadjuvant chemoradiation with CT-based radiomics
por: Wang, Fuqiang, et al.
Publicado: (2022)

MRI-based radiomics of rectal cancer: preoperative assessment of the pathological features
por: Ma, Xiaolu, et al.
Publicado: (2019)

Neoadjuvant chemoradiation therapy and pathological complete response in rectal cancer
por: Ferrari, Linda, et al.
Publicado: (2015)

DNA methylation-based signature of CD8+ tumor-infiltrating lymphocytes enables evaluation of immune response and prognosis in colorectal cancer
por: Zou, Qi, et al.
Publicado: (2021)

Multi-modal radiomics model to predict treatment response to neoadjuvant chemotherapy for locally advanced rectal cancer
por: Li, Zheng-Yan, et al.
Publicado: (2020)

Evaluating treatment response to neoadjuvant chemoradiotherapy in rectal cancer using various MRI-based radiomics models
por: Li, Zhihui, et al.
Publicado: (2021)

Predicting Treatment Response to Neoadjuvant Chemoradiotherapy in Rectal Mucinous Adenocarcinoma Using an MRI-Based Radiomics Nomogram
por: Li, Zhihui, et al.
Publicado: (2021)

Application of Radiomics in Predicting Treatment Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer: Strategies and Challenges
por: Chen, Rui, et al.
Publicado: (2022)

CT radiomics identifying non‐responders to neoadjuvant chemoradiotherapy among patients with locally advanced rectal cancer
por: Zhang, Zinan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_eachgqju8ag79o5npa0ugeekbf